Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Elevated risk of opportunistic viral infection in patients with Crohn's disease during biological therapies: a meta analysis of randomized controlled trials.

Wang X, Zhou F, Zhao J, Zhou R, Huang M, Li J, Wang W, Xu S, Xia B.

Eur J Clin Pharmacol. 2013 Nov;69(11):1891-9. doi: 10.1007/s00228-013-1559-8. Epub 2013 Jul 25.

PMID:
23884581
2.

Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.

Ford AC, Peyrin-Biroulet L.

Am J Gastroenterol. 2013 Aug;108(8):1268-76. doi: 10.1038/ajg.2013.138. Epub 2013 May 7.

PMID:
23649185
3.

Enteral nutritional therapy for induction of remission in Crohn's disease.

Zachos M, Tondeur M, Griffiths AM.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000542. Review.

PMID:
17253452
4.

Natalizumab for induction of remission in Crohn's disease.

Macdonald JK, McDonald JW.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006097. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD006097.

PMID:
16856112
5.

Cyclosporine for induction of remission in Crohn's disease.

McDonald JW, Feagan BG, Jewell D, Brynskov J, Stange EF, Macdonald JK.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000297. Review.

PMID:
15846602
6.

Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis.

Kourbeti IS, Ziakas PD, Mylonakis E.

Clin Infect Dis. 2014 Jun;58(12):1649-57. doi: 10.1093/cid/ciu185. Epub 2014 Mar 18. Review.

PMID:
24647016
7.

Natalizumab for induction of remission in Crohn's disease.

MacDonald JK, McDonald JW.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. Review.

PMID:
17253580
8.

Enteral nutritional therapy for inducing remission of Crohn's disease.

Zachos M, Tondeur M, Griffiths AM.

Cochrane Database Syst Rev. 2001;(3):CD000542. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD000542.

PMID:
11686966
9.

Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Naidoo K, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008414. doi: 10.1002/14651858.CD008414.pub2. Review.

PMID:
21249709
10.

Vaccines for prophylaxis of viral infections in patients with hematological malignancies.

Cheuk DK, Chiang AK, Lee TL, Chan GC, Ha SY.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006505. doi: 10.1002/14651858.CD006505.pub2. Review.

PMID:
21412895
11.

Sargramostim (GM-CSF) for induction of remission in Crohn's disease.

Roth L, Macdonald JK, McDonald JW, Chande N.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008538. doi: 10.1002/14651858.CD008538.pub2. Review.

PMID:
22071853
12.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Prefontaine E, Macdonald JK, Sutherland LR.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000545. doi: 10.1002/14651858.CD000545.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(6):CD000545.

PMID:
19821270
13.

Interventions for prevention of post-operative recurrence of Crohn's disease.

Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006873. doi: 10.1002/14651858.CD006873.pub2. Review.

PMID:
19821389
14.

Recombinant human interleukin 10 for induction of remission in Crohn's disease.

Buruiana FE, Solà I, Alonso-Coello P.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD005109. doi: 10.1002/14651858.CD005109.pub3. Review.

PMID:
21069683
15.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Prefontaine E, Macdonald JK, Sutherland LR.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD000545. doi: 10.1002/14651858.CD000545.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD000545.

PMID:
20556747
16.

[Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFalpha) therapy].

Salavert M, Bastida G, Pemán J, Nos P.

Rev Iberoam Micol. 2009 Sep 30;26(3):213-7. doi: 10.1016/j.riam.2009.01.001. Epub 2009 Jul 26. Spanish.

PMID:
19635442
17.

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Behm BW, Bickston SJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Review.

PMID:
18254120
18.

[Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy].

Bernal I, Domènech E, García-Planella E, Cabré E, Gassull MA.

Gastroenterol Hepatol. 2003 Jan;26(1):19-22. Spanish.

PMID:
12525323
19.

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH.

J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x.

PMID:
21039834
20.

Current knowledge and systematic review of viruses associated with Crohn's disease.

Wagner J, Sim WH, Lee KJ, Kirkwood CD.

Rev Med Virol. 2013 May;23(3):145-71. doi: 10.1002/rmv.1720. Epub 2012 Jun 6. Review.

PMID:
22674582

Supplemental Content

Support Center